Hospitals do not pay late. They pay on a different calendar.
Your invoice says Net 30. The hospital's payment cycle runs 90 to 120 days — not because the accounts payable department is negligent but because the approval chain has six layers, the budget is allocated quarterly, and the purchase order you thought was a purchase order was actually a requisition that needs three more signatures before it becomes one.
If you sell medical devices, pharmaceutical supplies, laboratory equipment, or healthcare IT to hospitals abroad, you already know this. What you may not know is whether the 97-day average is a payment cycle or a payment problem — and what to do when the cycle becomes a default.
Why healthcare is different
Hospital procurement is structurally slower than commercial B2B. A manufacturing company that receives your goods signs a delivery note and processes the invoice through a two-step approval. A hospital receives your goods through a supply chain department that is separate from the clinical department that ordered them, which is separate from the finance department that authorises payment, which is separate from the treasury that releases funds.
In public hospitals — which account for the majority of healthcare systems in the EU, the UK, and the Middle East — the payment cycle is further constrained by government budget allocation. The hospital may have accepted your goods in March but may not receive the budget disbursement to pay you until June. This is not non-payment. It is a funding cycle you are caught inside.
When the cycle becomes a default
The distinction matters for your collection strategy. A hospital that pays at 97 days consistently is a slow payer with a structural cycle. The correct response is to price the delay into your terms — longer payment terms, higher prices, or early payment discounts that incentivise faster processing.
A hospital that stops paying entirely — where the 97-day cycle stretches to 180 days, then 270, then silence — has a different problem. Budget cuts, restructuring, administrative failure, or genuine financial distress. Public hospitals in Southern Europe, parts of the Middle East, and many emerging markets have historically accumulated arrears that stretch into years.
The trigger for escalation is not the day count. It is the pattern break. If the hospital always pays at 90 days and is now at 150 with no communication, something has changed. That change is the signal.
Collecting from public institutions
Public hospitals are government entities in most jurisdictions. You cannot threaten insolvency proceedings against a government hospital — the state does not go bankrupt in the conventional sense. You can, however, pursue the debt through administrative courts, through the relevant ministry of health, or through EU-level mechanisms if the hospital is in a member state and EU procurement directives apply.
In Spain, public healthcare arrears have historically been a significant problem. The Ley de Morosidad (late payment law) provides statutory interest on overdue public-sector payments and administrative mechanisms to escalate. In Italy, the Codice degli Appalti Pubblici governs public procurement disputes including payment delays. Each jurisdiction has its own route, and the route is administrative, not commercial.
A collection agency with healthcare sector experience navigates these routes. The process is different from commercial B2B collection — it involves public procurement law, government finance departments, and sometimes political escalation. It is also slower. But the debtor is a government institution, which means the assets exist and the obligation is statutory.
Private hospitals
Private hospitals are commercial entities. The collection process is the same as for any commercial debtor — amicable phase, legal proceedings, enforcement. The only difference is the procurement complexity that may have caused the delay in the first place. A private hospital chain that owes you €200,000 is a debtor with assets, revenue, and a reputation to protect. The standard collection tools apply.
The assessment determines which type of institution you are dealing with, which jurisdiction governs, and which route — administrative or commercial — produces recovery. The 97-day average is a starting point, not a verdict.
Elena Moreau
Senior Market Analyst, EU Region
Elena leads Collecty's European market intelligence, tracking industry size, NPL portfolios, and cross-border recovery trends. She works with creditors across the EU, the UK, and connected jurisdictions to translate regulatory change into commercial strategy. Before Collecty, she spent eight years in credit risk and receivables analytics across three European banks.